Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

Isotretinoin, widely used for treating severe acne, has also been prescribed off-label for hidradenitis suppurativa (HS). While effective in some cases, isotretinoin is known to cause psychiatric side effects. This case report discusses a 24-year-old male with HS who developed severe nightmares after the isotretinoin dosage was increased. Initially prescribed to manage his HS symptoms, the drug led to vivid, distressing nightmares that significantly disrupted his sleep, resulting in the discontinuation of treatment. The symptoms resolved upon cessation of isotretinoin, and a probable association was confirmed using the Naranjo algorithm. The patient was later transitioned to adalimumab, a biologic therapy for HS. This case highlights the need for careful psychiatric monitoring during isotretinoin therapy and emphasizes the importance of considering alternative treatments in cases of intolerable side effects. Further research is necessary to better understand the psychiatric implications of isotretinoin, including sleep disturbances like nightmares.

Authors

Institutions

Publication Details

Journal
Dermatology Reports
Published
2024-12-06
DOI
https://doi.org/10.4081/dr.2024.10171
Citations
1
Primary Topic
Hidradenitis Suppurativa and Treatments
Type
article
Field-Weighted Citation Impact
0.53
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

Sara Alharbi, Shumukh Alqahtani, Seham Alsulami, Fawaz Aljehani
1 citations
Dermatology Reports
Hidradenitis Suppurativa and Treatments
0.53
article

Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

Sara Alharbi, Shumukh Alqahtani, Seham Alsulami, Fawaz Aljehani
article en
1 citations

Abstract

Isotretinoin, widely used for treating severe acne, has also been prescribed off-label for hidradenitis suppurativa (HS). While effective in some cases, isotretinoin is known to cause psychiatric side effects. This case report discusses a 24-year-old male with HS who developed severe nightmares after the isotretinoin dosage was increased. Initially prescribed to manage his HS symptoms, the drug led to vivid, distressing nightmares that significantly disrupted his sleep, resulting in the discontinuation of treatment. The symptoms resolved upon cessation of isotretinoin, and a probable association was confirmed using the Naranjo algorithm. The patient was later transitioned to adalimumab, a biologic therapy for HS. This case highlights the need for careful psychiatric monitoring during isotretinoin therapy and emphasizes the importance of considering alternative treatments in cases of intolerable side effects. Further research is necessary to better understand the psychiatric implications of isotretinoin, including sleep disturbances like nightmares.

Dermatology ReportsVol. 17(2)
Umm al-Qura University (SA), Eastern Health (AU), King Abdulaziz Hospital (SA)
Good health and well-being
Openalex Percentile: Top 26%
Hidradenitis Suppurativa and Treatments
0.53
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights — Sara Alharbi, Shumukh Alqahtani, et al. · Dermatology Reports (2024) | TGRS Research Map | TGRS